All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 3, 2021
Home » Blogs » BioWorld Perspectives » What’s in a Biotech Name? It’s Greek to Me

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

What’s in a Biotech Name? It’s Greek to Me

Oct. 13, 2011
By Jennifer Boggs
No Comments

OK, you’re a biotech entrepreneur and you’ve found some interesting new technology. You’ve secured some seed funding, found some lab space and filled out all the appropriate paperwork for a business license. All’s that left to incorporate your brand new biotech start-up? A name.

Coming up with a good name is important. You need a name that speaks to your cause – and is easy to speak. After all, there will be many a presentation in your future, and you can’t afford to lose valuable time on pronunciation lessons.

But more than that, a good name is a way to impress other brainiacs in the biotech space, a way to show your colleagues that you’re more than a scientist – you’re a great reader of history and mythology, you appreciate art and opera, you are a sophisticate, you have traveled the world. Or maybe you just have a well-developed sense of irony. Or a serious yen for a really good pun.

I remember interviewing the CEO of a start-up company for BioWorld’s NewCo News series on AltraVax Inc. and, when I asked how the company got it’s the name, the CEO joked, “Well, it wasn’t easy. All the Greek gods and monsters were taken.”

Really, though, any Greek word will do, especially if there’s a connection to medicine. Here are some of my favorites:

2009 start-up Euthymics Bioscience Inc., named for a Greek word meaning “good mood,” appropriate since its lead program is in major depressive disorder;

Calithera Biosciences Inc., whose name comes from the Greek word “kallos,” meaning “harmony” or “symmetry”;

Ikaria Inc., named after the Greek island renowned for the healing qualities of its waters and home to the mythical Icarus;

U.S.-Chinese start-up Ascletis Inc., named after Asclepius, the Greek god of medicine;

Epiomed Therapeutics Inc., named by combining the Greek goddess of relieving pain, Epione, combined with the word “medicine”:

and execs at Oncothyreon Inc. doubled up on their Greek, combining the words for “tumor” and “shield” when creating its moniker.

There are many others. And, hey, Latin words are big, too. There’s Senex Biotechnology Inc., working on drugs for aging whose name means “old” in Latin. Aestus Therapeutics Inc.’s name comes from the Latin word meaning “passionate fire,” and Vicept Therapetuics Inc. combined “vita,” meaning life, and “receptus,” meaning to take back.

Sometimes founders pull from their own inspirations. For instance, I’ve talked to execs who christened their firms after their favorite sports teams (Chelsea Therapeutics Inc.), while others have gone for the names of locations or nearby towns (Coronado Biosciences Inc.)

And, sometimes, there seems a bit of a superstitious connection. When coming up with a name for his latest venture, biotech entrepreneur Alan Auerbach clearly is hoping to carry a little good will from his previous success with Cougar Biotechnology Inc. And it might be working. His new firm, Puma Biotechnology Inc. closed a $55 million private placement just last week. (Perhaps if Puma succeeds, Auerbach will return with Panther Biotechnology or Catamount Biotechnology.)

Clever names also make for some interesting partnerships as well. For instance, Ironwood Pharmaceuticals Inc., named after a hardwood tree, has a deal with Forest Laboratories Inc. There’s also the proofreader’s nightmare of a partnership between Clavis Pharma ASA and Clovis Oncology Inc.

And, seriously folks, am I the only one waiting with fingers crossed for a licensing deal uniting Osiris Therapeutics Inc. with its counterpart of Egyptian myth, Isis Pharmaceuticals Inc.? The geek-out headline potential alone would be more than worth it.

But that’s me.

Got a favorite biotech company name? We’d love to hear it!

 

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 2.
  • Gloved hand places sample tubes in PCR system

    COVID-19 test makers are adapting for variants

    BioWorld MedTech
    As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for March 2.
  • Celltrion-Regkirona-2-9

    Celltrion wins first conditional Korean approval for COVID-19 antibody Regkirona

    BioWorld
    HONG KONG – Celltrion Inc. has received conditional marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its anti-COVID-19 monoclonal...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing